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Abstract
Background: Specialist community teams often support people with dementia who experience crisis. These teams may vary
in composition and models of practice, which presents challenges when evaluating their effectiveness. A best practice model for
dementia crisis services could be used by teams to improve the quality and effectiveness of the care they deliver.
Objective: The aim of this study is to examine the feasibility of conducting a large-scale randomized controlled trial comparing
the AQUEDUCT (Achieving Quality and Effectiveness in Dementia Using Crisis Teams) Resource Kit intervention to treatment
as usual.
Methods: This is a multisite feasibility study in preparation for a future randomized controlled trial. Up to 54 people with
dementia (and their carers) and 40 practitioners will be recruited from 4 geographically widespread teams managing crisis in
dementia. Quantitative outcomes will be recorded at baseline and at discharge. This study will also involve a nested health
economic substudy and qualitative research to examine participant experiences of the intervention and acceptability of research
procedures.
Results: Ethical approval for this study was granted in July 2019. Participant recruitment began in September 2019, and as of
September 2020, all data collection has been completed. Results of this study will establish the acceptability of the intervention,
recruitment rates, and will assess the feasibility and appropriateness of the outcome measures in preparation for a large-scale
randomized controlled trial.
Conclusions: There is a need to evaluate the effectiveness of crisis intervention teams for older people with dementia. This is
the first study to test the feasibility of an evidence-based best practice model for teams managing crisis in dementia. The results
of this study will assist in the planning and delivery of a large-scale randomized controlled trial.
International Registered Report Identifier (IRRID): DERR1-10.2196/18971
(JMIR Res Protoc 2020;9(10):e18971) doi: 10.2196/18971
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Introduction
Background
Dementia is a progressive condition that affects over 850,000
people in the United Kingdom [1]. The cognitive, behavioral,
and psychological symptoms of dementia include memory loss,
changes in reasoning and planning skills, and communication
difficulties that may impair ability to perform daily activities
[2]. Improving dementia care remains a key priority from the
Prime Minister’s Challenge on Dementia [3]. Community
support, with the aim of reducing hospital admissions, is one
way to respond to this policy initiative; however, fluctuations
in the health and social circumstances of the person with
dementia may cause a breakdown in care which could lead to
crisis.
A dementia mental health crisis can be defined as “a need for
urgent mental health assessment and intervention for people
with dementia who live in the community” (from Hoe J, Ledgerd
R, Devine M, Toot S, Challis D, Orrell M. Home Treatment
Manual 2012 Version 4. Support at Home: Interventions to
Enhance Life in Dementia (SHIELD); unpublished). Crisis
situations in dementia are common and often result in a hospital
admission. Risk factors for breakdown of care at home include
increased carer burden and inadequate social support [4].
Increased contact with general practitioners and case manager
consultations are recommended to help manage instances of
crisis [5]. Support for people with dementia and their carers at
a time of crisis is often managed through secondary mental
health services. These services involve teams that vary in name
and composition and may include crisis resolution and home
treatment teams and dementia rapid response teams, though in
some instances, there are no suitable services. Some teams may
be commissioned to specifically provide support for older
people, while others may be nonage-defined. From here on in,
these services will be referred to as teams managing crisis in
dementia. A recent scoping survey [6] highlighted the disparity
in services across England; teams managing crisis in dementia
vary in terms of name, set-up, delivery, policy, and procedures.
Further high-quality evidence is required to support the
effectiveness of teams managing crisis in dementia in reducing
hospital admissions and preventing breakdown of care at home,
and to improve knowledge on how teams can be supported to
deliver care for people with dementia in crisis.
Preliminary Work
The Achieving Quality and Effectiveness in Dementia Using
Crisis Teams (AQUEDUCT) program comprises 3 work
packages following the Medical Research Council’s Framework
for the Development and Evaluation of Randomized Controlled
Trials for Complex Interventions [7]. The first work package
(WP1) consisted of 2 strands: a systematic literature review to
examine the effectiveness of crisis interventions for older people
and a scoping review to map and understand operational
procedures in current services [6], and subsequently, qualitative
work (including interviews; focus groups; consultations; and a
consensus conference involving people with dementia, carers,
practitioners, and stakeholders) was used to identify and
establish agreement about key elements of best practice in teams
managing crisis in dementia.
The strands from WP1 contributed to the development of a
model of best practice comprising 50 best practice statements,
a best practice tool, and a resource kit [8], after which, 12 teams
managing crisis in dementia and 5 noncrisis older adult mental
health teams field-tested the AQUEDUCT best practice tool
and resource kit. The feedback from these teams was used to
amend the resource kit for future use in the second work package
(WP2)—the feasibility study. Findings from this feasibility
study will be used to inform the future large-scale randomized
controlled trial in the third work package (WP3). This paper
describes the protocol for WP2 only.
Aims and Objectives
The aims of WP2 of the AQUEDUCT research program were
to (1) conduct a feasibility study of use of the resource kit in
relation to practice, care outcomes, and costs; (2) gather
feedback from participants about the acceptability and feasibility
of the research procedures; and (3) refine the resource kit for
use in the randomized controlled trial in order to (1) determine
the feasibility of recruitment to a large-scale randomized
controlled trial; (2) refine the eligibility criteria for teams
managing crisis in dementia for a future definitive randomized
controlled trial; (3) determine the relevance and acceptability
to National Health Service (NHS) practitioners; (4) determine
the acceptability to people with dementia, carers, and NHS
practitioners of the trial procedures; (5) assess the ability of the
NHS sites to implement the resource kit; (6) assess the training
and support needs for NHS practitioners using the resource kit;
(7) evaluate resource kit uptake and fidelity when used through
NHS services; (8) assess follow-up and outcome completion
rates; (9) determine the relevance and acceptability of a range
of outcome measures to inform selection of the primary outcome
for the main trial; and (10) evaluate the utility and acceptability
of resource use questionnaires for use in an economic evaluation
in a future randomized controlled trial.
The design of WP2 is illustrated in Figure 1. The main
component—WP2.1—is the overall feasibility study; WP2.2
will examine the feasibility of an economic evaluation of the
resource kit, and WP2.3 is a qualitative evaluation of the
experience of using the resource kit and its acceptability.
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Figure 1. Design and components of WP2.
Methods
Site Selection
This is a multisite pre–post feasibility study with all sites
allocated to the AQUEDUCT resource kit intervention.
Recruitment will take place at 4 sites which will be purposively
selected from across England to ensure a diverse range of teams
managing crisis in dementia models and service user
demographics. The number of teams approached and reasons
for teams declining to participate will be documented. This will
allow structural or process issues which influence participation
to be identified and considered for how they may impact site
selection in the main trial.
Criteria
Inclusion criteria will be as follows: (1) teams managing mental
health crises in dementia in community settings, (2) people with
dementia receiving input from the teams managing crisis in
dementia during the team’s use of the resource kit, and (3) carers
providing support for a person with dementia in receipt of input
(using the resource kit) from the teams managing crisis in
dementia.
Exclusion criteria will be as follows: (1) team is not defined by
NHS Trust as having a role in dementia mental health crisis
management, (2) team does not meet the following definition
for mental health crisis management—providing urgent mental
health assessment and intervention for people with dementia in
the community, and (3) team is not able to demonstrate capacity
and capability to complete required research activities.
Participant Recruitment
This study will recruit 3 different groups of participants: teams
managing crisis in dementia practitioners, people living with
dementia, and carers. Recruitment will take place in different
ways. All participants will be asked to consent separately, by
signing relevant consent forms for each stage of the research
with which they wish to engage. This section presents the
recruitment pathway for WP2.1, the main feasibility study.
Recruitment for WP2.2 and WP2.3 will be outlined later in the
protocol.
Practitioners will be identified and recruited from participating
teams managing crisis in dementia. Once the NHS Trust has
formally agreed to participate in the study, each team manager
or senior practitioner will receive an information pack which
will include an information sheet for potential practitioner
participants. The team manager will identify 2 practitioners who
will act as research coordinators for the site; these practitioners
will be given up to 3 days to decide whether or not they wish
to participate. A member of the AQUEDUCT research team
will then conduct a site set-up visit to answer any questions and
seek written informed consent. From this point, the research
coordinators will be responsible for arranging and confirming
consent with other practitioners at the site. All teams will
complete good clinical practice [9] training before their study
start date.
People with dementia and carers who are referred to the teams
managing crisis in dementia caseload during the first 2 weeks
of each team's implementation of the resource kit will be
identified and recruited by participating practitioners. Potentially
eligible participants will be approached by the practitioner who
will give them an appropriate information sheet and explain to
them that the team managing crisis in dementia has agreed to
participate in the AQUEDUCT research program. Potential
participants will be given up to 3 days to decide whether or not
they wish to participate; if in agreement, they will then sign a
consent form.
Where a carer also agrees to participate in the study, the carer
will be asked to provide written informed consent for their own
participation in the feasibility study. A carer’s decision to
participate or not will not affect the involvement of a consenting
person with dementia.
Sample Size
The aim of this feasibility study is to estimate rates of
recruitment and completion rates, and to refine eligibility criteria
and other research procedures; therefore, no formal sample size
calculation is required. The proposed sample size includes a
total of 40 teams managing crisis in dementia practitioners and
54 people with dementia and carers across the 4 NHS sites; this
is considered sufficient to establish feasibility and to inform the
future large-scale randomized controlled trial.
Ethics and Mental Capacity
Ethical approval was given by the West Midlands–Coventry
and Warwickshire Research Ethics Committee (19/WM/0132)
on July 14, 2019 and Health Research Authority approval was
given on July 15, 2019. The study sponsor is Nottinghamshire
Health care NHS Foundation Trust.
On first contact with the person with dementia, and at every
subsequent meeting with a person with dementia, the teams
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managing crisis in dementia practitioner will determine the
mental capacity (according to the Mental Capacity Act 2005
[10]) of the person with dementia to give informed consent to
take part in the research. Where the person with dementia is
thought not to have the mental capacity to give informed
consent, the view of the person with dementia’s carer will be
taken into account as they will have a greater knowledge of the
person with dementia’s abilities over time. The carer consultee
will be asked to consider what would be in the best interests of
the person with dementia according to their previous or currently
expressed views. In these instances, the carer will be provided
with a consultee information sheet and a carer consultee
declaration form.
Withdrawal
People with dementia can withdraw from the study at any time
without any impact on their current or future care. Carers may
also withdraw from the study, and this will not affect the person
with dementia’s continued involvement in the study. Participant
information sheets and consent forms will inform participants
of their right to withdraw from the research for any reason
(which does not need to be stated) and at any time, without any
effect on their employment (for teams managing crisis in
dementia practitioners) or input from services (for people with
dementia and carers).
Patient and Public Involvement
Throughout the development of the AQUEDUCT research
program, the research team has extensively consulted with
people with dementia and their carers. Patient and public
involvement was integrated throughout WP1, to inform
development of the AQUEDUCT resource kit. The protocol for
WP2 has been developed in consultation with the AQUEDUCT
patient and public involvement reference group, and all study
documentation and participant recruitment procedures have
been reviewed by patient and public involvement
representatives.
AQUEDUCT Intervention
The AQUEDUCT resource kit is an online resource for teams
managing crisis in dementia, designed to assist teams in
evaluating and improving their practice according to the best
practice model developed in WP1 of the research program. The
resource kit comprises 3 components: the best practice tool
which enables teams managing crisis in dementia to evaluate
their practice according to 50 best practice statements, the home
treatment package developed during the National Institute for
Health Research (NIHR)–funded Support at
Home—Interventions to Enhance Life in Dementia study (from
Hoe J, Ledgerd R, Devine M, Toot S, Challis D, Orrell M. Home
Treatment Manual 2012 Version 4. Support at Home:
Interventions to Enhance Life in Dementia (SHIELD);
unpublished), and a collection of templates and documents that
can be used directly or adapted by teams to suit their practice.
At the set-up visit, or subsequently, participating practitioners
will complete online training on use of the AQUEDUCT
resource kit. They will then complete a posttraining
self-assessment to provide information about the effectiveness
of the online training. The self-assessment consists of
multiple-choice questions that assess the ability, training, and
support needs of NHS practitioners using the resource kit. The
aim of this assessment is to identify any misunderstandings or
areas that require further explanation. Topics focus on study
procedures and the best practice toolkit.
For the purpose of the feasibility study, each team will be given
3 weeks to complete the best practice tool before the
implementation phase, to determine areas in which the teams
managing crisis in dementia could improve practice. The team
will then implement relevant elements of the resource kit that
will assist them in improving practice during an 8-week
implementation phase. The team will recomplete the best
practice tool at the end of the implementation phase.
The AQUEDUCT research team will have weekly contact with
team practitioners to obtain feedback and provide support for
implementation of the resource kit. Support elements will be
monitored by the research team to identify usage and costs.
teams managing crisis in dementia practitioners will maintain
activity records to monitor time spent implementing the resource
kit in practice during the implementation phase.
Study Outcomes
Feasibility Study Outcomes (WP2.1)
One of the main aims of the feasibility study is to determine the
most suitable outcome measures for the proposed randomized
controlled trial. The primary outcome measure to be used in the
main trial will be selected from among those described below,
based on relevance and acceptability in this feasibility study.
Outcome Measures for the Person With Dementia
Both the self-completed and proxy versions of the Dementia
Quality of Life Questionnaire [11], measuring quality of life
for people with dementia, will be used. The Client Satisfaction
Questionnaire [12], measuring user satisfaction of service
received; the Neuropsychiatric Inventory [13], a carer-completed
measure that assesses neuropsychiatric symptoms for the person
with dementia rating the frequency of the symptoms on a 4-point
Likert scale, and severity on a 3-point scale; and the Bristol
Activities of Daily Living Scale, a carer-rated measure that
assesses daily living activities [14] will also be used.
Outcome Measures for the Carer
European Quality of Life 5 Dimensions questionnaire [15],
measuring health-related quality of life; Hospital Anxiety and
Depression Scale, a self-completed measure that assesses anxiety
and depression [16]; the Neuropsychiatric Inventory severity
of symptoms (3-point scale) and the impact of symptoms
manifestations (5-point scale) to determine caregiver distress
associated with neuropsychiatric symptoms [13]; and Client
Satisfaction Questionnaire [12] will be used.
Outcome Measures for Teams Managing Crisis in
Dementia
The following data will be collected: initial best practice tool
score for the teams managing crisis in dementia; final best
practice tool score for the teams managing crisis in dementia;
number of hospital admissions for the teams managing crisis
in dementia over the study period; total number of referrals
JMIR Res Protoc 2020 | vol. 9 | iss. 10 | e18971 | p. 4http://www.researchprotocols.org/2020/10/e18971/
(page number not for citation purposes)
Broome et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
received by the teams managing crisis in dementia over the
study period (to include nondementia referrals); number of
specific dementia crisis referrals received by the teams managing
crisis in dementia over the study period; number of inappropriate
referrals to the teams managing crisis in dementia over the study
period; teams managing crisis in dementia practitioner
absenteeism over the study period; total number of hospital beds
available to the service or organization during the study period;
and number of hospital beds available to the teams managing
crisis in dementia over the study period.
Health Economic Outcomes (WP2.2)
This substudy will test the feasibility of conducting a full
economic evaluation of the resource kit in the future randomized
controlled trial. The aim will be to test the relevance and
acceptability to people with dementia and carers of the
questionnaires to be considered for the full economic evaluation
in the large-scale randomized controlled trial. It will include at
least 4 carers of people with dementia recruited by each of the
4 teams to reflect living arrangements such as a spouse living
with a person with dementia or an adult-child living elsewhere.
It will involve an analysis of the specific cost of the resource
kit, identify appropriate sources of data to be used in the full
economic evaluation, and how best to collect these data.
To assess the feasibility of the economic evaluation, carers who
are taking part in WP2.1 will be approached by team
practitioners and asked if they will consider participating in the
feasibility study of the economic evaluation as well. If agreeable,
potential participants will then be contacted by a member of the
AQUEDUCT research team and will be provided with an
information sheet, given an opportunity to ask questions, and
given up to 3 days to decide whether or not they wish to
participate in this part of the research. If they wish to be
involved, participants will sign the relevant consent form.
To calculate the cost of the resource kit, the following
components will be considered: (1) the cost of producing and
maintaining the resource kit, including the cost of producing
and maintaining the best practice tool, all resource materials in
the resource kit, all guidance and explanatory information, and
the website which supports the resource kit and (2) the cost of
skills training for teams managing crisis in dementia
practitioners in the use of the resource kit, including all training
materials.
It will be assumed that, in the large-scale randomized controlled
trial, the lifetime incremental cost per quality-adjusted life year
gained for the resource kit versus treatment as usual will be
estimated from NHS and Personal Social Services perspectives
and from a societal perspective. The resources used and unit
cost data for these components will be collected through a
modified version of the Clinical Service Receipt Inventory [17].
Potential sources of health-related quality of life data suitable
for estimating quality-adjusted life years for people with
dementia and carers will also be collected.
Qualitative Evaluation of Participant Experience
(WP2.3)
This part of the study will evaluate the experience of applying
the research methodology and the acceptability and relevance
to participants of using or receiving input from the teams
managing crisis in dementia with the resource kit. Findings
from the qualitative substudy will be used to modify the resource
kit and research methods to be used in the large scale
randomized controlled trial. Team practitioners who were
involved in the main part of the feasibility study will be
approached by a member of the AQUEDUCT research team to
invite them to participate in the qualitative evaluation. Potential
participants will be given a relevant information sheet, an
opportunity to ask questions, and up to 3 days to decide whether
or not they wish to participate in advance of giving consent.
All potentially eligible people with dementia and carers will be
provided with a relevant information sheet; the research will be
explained to them verbally, and potential participants will have
the opportunity to ask questions and will be given up to 3 days
to decide whether or not they wish to participate in advance of
giving consent.
Once informed consent has been provided, team practitioners,
people with dementia, and carers will complete bespoke
questionnaires to explore their perspectives of how the research
procedures were applied and of the acceptability and relevance
of using, or receiving input on, the resource kit. Practitioners
will be asked to answer statements such as “Was the Best
Practice Toolkit training an appropriate length of time?’” with
either yes, somewhat, or no. The questionnaire also includes
some open-ended questions such as “If you answered no, please
provide further details.” The framework for the bespoke
questionnaires is outlined Textbox 1.
Textbox 1. Framework for qualitative substudy.
Experience of
• online training and related activities (teams managing crisis in dementia only)
• completing the best practice tool (teams managing crisis in dementia only)
• recruiting people with dementia or carers and of being recruited (all participants)
• using the resource kit (teams managing crisis in dementia only)
• completing other research-related activity (teams managing crisis in dementia only)
• completing the questionnaires (all relevant participants)
• contact with the AQUEDUCT research team (all relevant participants)
• clinical team input (people with dementia and carers only)
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Data Collection
Table 1 outlines procedures and assessments at each time point
during the study. Upon recruitment, team practitioners will
complete a demographic information sheet. Each team will
complete the best practice tool at 2 time points: baseline
(preimplementation) and study close (postimplementation). The
qualitative questionnaires will be completed by team
practitioners at the end of the 8-week implementation phase.
Table 1. Study procedures for WP2.
Study close
(2 weeks)
Implementation
phase (8 weeks)
BaselineStudy set-up
(3 weeks)
Assessments and procedures
WP2.1a
Practitioners
XInformed consent
XDemographic information
XXBest practice tool intervention
People with dementia
XEligibility screen
XInformed consent
XDemographic information
XXDementia Quality of Life Questionnaire
XClient Satisfaction Questionnaire
Carers
XEligibility screen
XInformed consent
XDemographic information
XXEuropean Quality of Life 5 Dimensions Questionnaire
XXHospital Anxiety and Depression Scale
XXClient Satisfaction Questionnaire
XXBristol Activities of Daily Living Scale
XXDementia Quality of Life Questionnaire-Proxy
XXNeuropsychiatric Inventory symptom frequency and severity
WP2.2
Carers
XInformed consent
XDemographic information
XXClient Service Receipt Inventory
XExperience questionnaire
WP2.3
Practitioners
XInformed consent
XDemographic information
XExperience questionnaire
People with dementia and carers
XInformed consent
XDemographic information
XExperience questionnaire
aWP: work package.
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Data will be collected at 2 time points for people with dementia
and carers. Upon recruitment, demographic information and
baseline questionnaires will be completed; follow-up
questionnaires will be completed at the end of the period during
which the person with dementia and the carer has received team
input. Participants not included in the study will be recorded
on the Person with Dementia and Carer data summary sheet.
The reason for noninclusion or the reason for declining to
participate will be recorded where possible.
Data Management
Upon signing a consent form, all participants will be allocated
a unique identification code to ensure anonymity. Individual
participant information obtained as a result of this research will
be considered strictly confidential. Confidentially will be
maintained through ongoing use of unique identifiers. All data
will be treated as confidential and the NHS Code of
Confidentiality [18], 2016 General Data Protection Regulation
[19], and 2005 Good Clinical Practice guidelines [9] will be
adhered to. Insurance and indemnity arrangements will be
covered by the study sponsor (Nottinghamshire Health care
NHS Foundation Trust).
Data Analysis
Data analysis to address the feasibility aims of this study will
be primarily descriptive. Feasibility outcomes will be estimated
using descriptive statistics (with 95% confidence intervals) and
will consider recruitment rates, retention rates, amount of
missing data, and intervention adherence. The rate of protocol
adherence will be reported in terms of participants (practitioners,
people with dementia, and carers) who adhere to the required
research activities. Key characteristics (personal, demographic
and, where appropriate, clinical information from the case report
form) will be compared between participants and those who are
ineligible or who do not consent to take part, to ascertain
adequacy of inclusion and exclusion criteria and likely
generalizability of this research to the required targeted
populations. The same characteristics will be compared between
those who complete all required research activities and those
who do not.
Process data will also be collected by the teams managing crisis
in dementia and the AQUEDUCT research team. This will
include the number of sites approached, the number of
participants approached as well as the number recruited, and
reasons for not participating given by those who decline to
participate. The teams managing crisis in dementia will also
record time spent on research activities and on implementing
the resource kit.
Adverse Events
No adverse events are anticipated. All adverse events will be
recorded in the case report form and the Person with Dementia
and Carer data summary sheet. Participants will be informed
that they can stop their participation at any time without any
impact on their employment or clinical input.
Results
Ethical approval for this study was granted in July 2019.
Participant recruitment began in September 2019, and as of
September 2020, all data collection has been completed.
Discussion
This protocol describes a multisite feasibility study of an
evidence-based best practice model for teams managing crisis
in dementia. Previous research revealed only limited evidence
in support of crisis teams reducing hospital admission rates, and
despite an increase in the number of published studies, their
designs remain methodologically limited [6]. The AQUEDUCT
resource kit addresses the current care gap by providing more
robust evidenced-based dementia crisis care model. This study
will add to knowledge concerning the feasibility and
acceptability of implementing a model of best practice for teams
managing crisis in dementia. Data gathered in this study will
also provide an opportunity to modify the AQUEDUCT resource
kit.
We anticipate that this information can be used to improve the
quality and effectiveness of crisis teams that work with people
with dementia. If the AQUEDUCT intervention is found to be
effective, this program could influence how services are
organized, with benefits for people with dementia and their
carers. The long-term impact of a standardized model of
dementia crisis care working may be to reduce hospital
admissions and to reduce care costs. These impacts may improve
quality of life for people with dementia and carers.
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